PULSE PRESSURE CLASSES AND DOSAGE OF THE MAIN GROUPS OF CARDIAC MEDICATIONS IN PATIENTS AT THE ANNUAL FOLLOW-UP PERIOD AFTER PACING

  • M. V. Pochinska V. N. Karazin Kharkiv National University https://orcid.org/0000-0001-6332-9266
  • M. I. Shevchuk V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
Keywords: pulse pressure, cardiac pacing, cardiac medications

Abstract

Dose factor of the main groups of cardiac medications in five pulse pressure (PP) classes was studied in 220 patients (110 men and 110 women) at the annual stage after pacing, the average age 70 ± 9 years. Patients with the IV and V class of PP require the administration of higher doses of antiarrhythmics, diuretics, calcium channel blockers and ACE inhibitors.

In patients after pacing, the dose factor of the main groups of cardiac medications correlates with the PP classes and, the greater the PP class, the greater the dose rate of the medications. After pacing an increase of the dose factor of antiarrhythmic drugs (amiodarone) in the early period and diuretics and ß-blockers throughout the observation period with an increase in the PP class is required. The long term period of pacing contribute to reduction of the dose factor of antiarrhythmic drugs (amiodarone), Ca-channel blockers and ACE inhibitors in all classes of PP, to a greater extent - in II and III classes. The dose factor of anticoagulants, antiplatelet agents, ARBs and HMG CoA reductase inhibitors does not depend on the PP class and does not change over the entire observation period. Patients after pacing with IV and V classes of PP require the higher doses of antiarrhythmics, diuretics, Ca-channel blockers and ACE inhibitors.

Downloads

Download data is not yet available.

Author Biographies

M. V. Pochinska, V. N. Karazin Kharkiv National University

Svobody sq., 6, Kharkiv, 61022, Ukraine

M. I. Shevchuk, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

Svobody sq., 6, Kharkiv, 61022, Ukraine

 

References

Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study / [C. Mancusi, E. Gerdts, G. de Simone et al.]. // Blood Press. – 2017. – No. 26. – p. 150–155.

Beat-to-beat, ambulatory hour-to-hour, and home day-to-day variabilities in blood pressure, pulse pressure, and heart rate in comparison with each other and with target-organ damage / J. K. Johansson,

P. J. Puukka, R. Virtanen, A. M. Jula. // Blood Press Monit. – 2015. – No. 20. – p. 113–120.

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association / [M. Brignole, A. Auricchio, G. Baron-Esquivias et al.]. // Eur Heart J. – 2013. – No. 34. – p. 2281–329.

Ellims A. H. Restoration of blood pressure control with pacemaker implantation in a patient with bradycardia and resistant hypertension: A case report / A. H. Ellims, J. A. Mariani, M. P. Schlaich // International Journal of Cardiology. – 2013. – Volume 167. – Issue 2. – p. e38–e40.

Kolomytseva I. N. Funktsional'nyy klass khronicheskoy serdechnoy nedostatochnosti i medikamentoznoye soprovozhdeniye u patsiyentov na godovom etape posle implantatsii elektrokardiostimulyatorov / I. N. Kolomytseva. // Canadian journal of education and engineering. – 2015. – No. 12. – p. 569–578.

Maltseva M. S. Importance of QTc interval duration in pacing parameters optimization and therapeutic management of the patients with permanent cardiac pacing / M. S. Maltseva, D. E. Volkov. // The Journal of V. N. Karazin Kharkiv National University. Series «Medicine». – 2014. – No. 27. – p. 50–73.

Shanina I. V. Frequency of detached cardiac drugs prescribing in patients of different classes QRS complex duration on the permanent pacing background / I. V. Shanina, D. E. Volkov. // The Journal of

V. N. Karazin Kharkiv National University. Series «Medicine». – 2014. – No. 27. – p. 33–37.

Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice / [A. Mazza, S. Lenti, L. Schiavon et al.]. // Adv Ther. – 2017. – No. 34. – p. 975–985.

Published
2017-12-28
How to Cite
Pochinska, M. V., & Shevchuk, M. I. (2017). PULSE PRESSURE CLASSES AND DOSAGE OF THE MAIN GROUPS OF CARDIAC MEDICATIONS IN PATIENTS AT THE ANNUAL FOLLOW-UP PERIOD AFTER PACING. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (34), 36-40. https://doi.org/10.26565/2227-6505-2017-34-06